… disease. This review focuses on the current treatments for inflammatory bowel disease. …
matory bowel disease because little is known about the effects of the drug in pregnancy. …

… IBD treatment. Recent advances in the management of IBD have led to a paradigm shift in
the treatment … In this review, the latest progress in IBD treatment is summarized to understand …

… Limitations of sulfasalazine include allergic reactions and side effects, largely attributed to
the sulfapyridine moiety, as well as its lack of efficacy in isolated small bowel disease that is …

… to treat patients based … colitis or Crohn’s disease before major treatment decisions are made.
It is important to rescope patients after 4 to 6 months of treatment to ensure that the bowel is …

… options exist for the treatment of IBD, a proportion of … treatment options for CD, while the
oral small molecules now offer an oral alternative for the treatment of moderate-to-severe disease…

… In summary, the quest for new treatment options in IBD is … being developed to treat Crohn’s
disease and ulcerative colitis. … patients with moderate to severe Crohn’s disease [6]. Results …

… medical treatment of patients with inflammatory bowel disease (IBD)… of IBD. However,
conventional therapies remain the cornerstone of … Citation95 Extended small bowel disease, …

… The continued discovery of novel therapeutic targets will provide rationale for a rich
pipeline of future therapeutics, which will change clinical practice at centers treating IBD. …

… of IBD as well as the major cytokines involved. We then discuss steps used to diagnose this
disease and the treatment … bowel diseases (IBDs) primarily include Crohn’s disease and …

… The gut microbiota plays an important role in the pathogenesis and complications of the two
main inflammatory bowel diseases: Crohn’s disease (CD) and ulcerative colitis. Alterations …